| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q2 2026 | 58 | 1,104,182 | LQDA, ETON, HROW, IRON | 13F-HR | 8/14/2026 | 000142050626001803 |
| Q1 2026 | 54 | 759,221 | HROW, LQDA, ETON, SLGL | 13F-HR | 5/15/2026 | 000142050626001151 |
| Q4 2025 | 54 | 757,893 | HROW, LQDA, ETON, RYTM | RESTATEMENT | 4/13/2026 | 000149315226016299 |
| Q3 2025 | 43 | 707,320 | HROW, ETON, LQDA, RYTM | 13F-HR | 11/14/2025 | 000149315225023429 |
| Q2 2025 | 41 | 494,141 | HROW, ETON, IMNM, SNWV | RESTATEMENT | 8/15/2025 | 000164117225024301 |
| Q1 2025 | 45 | 449,152 | HROW, ETON, SNWV, LQDA | 13F-HR | 5/15/2025 | 000164117225010914 |
| Q4 2024 | 39 | 571,422 | HROW, TGTX, CDXS, ETON | 13F-HR | 2/14/2025 | 000149315225006852 |
| Q3 2024 | 44 | 599,558 | HROW, TGTX, OCUL, ARVN | 13F-HR | 11/14/2024 | 000149315224045811 |
| Q2 2024 | 51 | 437,656 | HROW, TGTX, OCUL, RYTM | 13F-HR | 8/14/2024 | 000149315224032150 |
| Q1 2024 | 52 | 458,857 | OCUL, HROW, TGTX, KROS | RESTATEMENT | 5/29/2024 | 000149315224021780 |
| Q4 2023 | 47 | 376,066 | HROW, TGTX, SLRN, RYTM | 13F-HR | 2/14/2024 | 000149315224006653 |
| Q3 2023 | 41 | 307,379 | HROW, SLRN, OCUL, TGTX | 13F-HR | 11/14/2023 | 000149315223041364 |
| Q2 2023 | 47 | 418,066 | SLRN, HROW, OCUL, TELA | 13F-HR | 8/14/2023 | 000149315223028636 |
| Q1 2023 | 41 | 333,877 | HROW, OCUL, TELA, RYTM | 13F-HR | 5/15/2023 | 000149315223016769 |
| Q4 2022 | 40 | 287,572 | HROW, TELA, RYTM, OCUL | 13F-HR | 2/10/2023 | 000149315223004277 |
| Q3 2022 | 42 | 242,132 | HROW, OCUL, RYTM, TELA | 13F-HR | 11/14/2022 | 000149315222032068 |
| Q2 2022 | 47 | 221,854 | HROW, OCUL, CDXS, CRNX | 13F-HR | 8/15/2022 | 000149315222022856 |
| Q1 2022 | 45 | 321,998 | OCUL, CDXS, CMRX, HROW | 13F-HR | 5/16/2022 | 000149315222013764 |
| Q4 2021 | 39 | 471,486 | CDXS, OCUL, CMRX, CLDX | 13F-HR | 2/14/2022 | 000149315222004434 |
| Q3 2021 | 48 | 535,390 | OCUL, CLDX, CDXS, CMRX | 13F-HR | 11/15/2021 | 000149315221028799 |
| Q2 2021 | 48 | 602,060 | OCUL, CMRX, CLDX, BBIO | 13F-HR | 8/16/2021 | 000149315221020260 |
| Q1 2021 | 58 | 680,804 | OCUL, CMRX, TARA, BBIO | 13F-HR | 5/17/2021 | 000149315221012017 |
| Q4 2020 | 59 | 765,570 | OCUL, TARA, EIDX, ETON | 13F-HR | 2/12/2021 | 000149315221003697 |
| Q3 2020 | 55 | 511,320 | OCUL, TARA, ETON, CRDF | 13F-HR | 11/16/2020 | 000149315220021694 |
| Q2 2020 | 48 | 495,150 | TARA, OCUL, NLTX, CCXI | 13F-HR | 8/14/2020 | 000149315220015902 |
| Q1 2020 | 44 | 377,363 | TARA, FTSV, OCUL, APTO | 13F-HR | 5/15/2020 | 000149315220009140 |
| Q4 2019 | 47 | 509,651 | EPZM, APTO, CDXS, FTSV | 13F-HR | 2/14/2020 | 000149315220002529 |
| Q3 2019 | 49 | 276,541 | CDXS, STXS, EPZM, IMMY | 13F-HR | 11/14/2019 | 000149315219017503 |
| Q2 2019 | 43 | 328,094 | CDXS, IMMY, AXGN, EPZM | 13F-HR | 8/14/2019 | 000149315219012567 |
| Q1 2019 | 53 | 361,134 | CDXS, AXGN, EPZM, CERC | 13F-HR | 5/15/2019 | 000149315219007425 |
| Q4 2018 | 47 | 267,975 | CDXS, AXGN, LOXO, AMRN | 13F-HR | 2/14/2019 | 000149315219002114 |
| Q3 2018 | 47 | 393,047 | AXGN, CDXS, LOXO, AMRN | 13F-HR | 11/14/2018 | 000149315218016123 |
| Q2 2018 | 36 | 386,358 | AXGN, LOXO, CDXS, FGEN | 13F-HR | 8/14/2018 | 000149315218011830 |
| Q1 2018 | 38 | 349,747 | AXGN, BPMC, LOXO, CDXS | 13F-HR | 5/14/2018 | 000149315218006822 |
| Q4 2017 | 35 | 312,298 | AXGN, BPMC, FGEN, LOXO | 13F-HR | 2/9/2018 | 000149315218001743 |
| Q3 2017 | 34 | 282,772 | BPMC, AXGN, FGEN, IMMU | 13F-HR | 11/14/2017 | 000149315217013210 |
| Q2 2017 | 41 | 239,398 | BPMC, AXGN, FGEN, LOXO | 13F-HR | 8/14/2017 | 000149315217009239 |
| Q1 2017 | 44 | 200,928 | BPMC, AXGN, FGEN, NVLNF | 13F-HR | 5/15/2017 | 000149315217005196 |
| Q4 2016 | 40 | 169,717 | BPMC, AXGN, ARIA, GNMX | 13F-HR | 2/21/2017 | 000114420417010166 |
| Q3 2016 | 44 | 191,082 | BPMC, AXGN, ARIA, MDGN | 13F-HR | 11/14/2016 | 000154692716000542 |
| Q2 2016 | 49 | 149,709 | AXGN, MDGN, ARIA, FGEN | RESTATEMENT | 8/12/2016 | 000154692716000514 |
| Q1 2016 | 52 | 160,362 | AXGN, ARIA, RARE, FGEN | RESTATEMENT | 5/27/2016 | 000154692716000499 |
| Q4 2015 | 53 | 239,178 | RARE, AXGN, FGEN, GERN | 13F-HR | 2/12/2016 | 000154692716000408 |
| Q3 2015 | 49 | 203,221 | CMRX, RARE, CEMP, AXGN | 13F-HR | 11/13/2015 | 000154692715000281 |
| Q2 2015 | 46 | 251,326 | CMRX, CEMP, RTRX, AMAG | 13F-HR | 8/14/2015 | 000154692715000231 |
| Q1 2015 | 37 | 215,386 | CMRX, CEMP, ARIA, RTRX | 13F-HR | 5/15/2015 | 000154692715000149 |
| Q4 2014 | 36 | 197,898 | CMRX, AGIO, CEMP, RTRX | 13F-HR | 2/13/2015 | 000154692715000070 |
| Q3 2014 | 30 | 128,295 | CMRX, PCYC, RTRX, ARIA | 13F-HR | 11/14/2014 | 000154692714000196 |
| Q2 2014 | 27 | 115,981 | CMRX, RTRX, ARIA, PCYC | 13F-HR | 8/14/2014 | 000154692714000159 |
| Q1 2014 | 30 | 135,373 | RTRX, ARIA, CMRX, PCYC | 13F-HR | 5/15/2014 | 000154692714000115 |
| Q4 2013 | 23 | 127,387 | GENTY, GERN, PCYC, ARIA | 13F-HR | 2/14/2014 | 000154692714000060 |
Investors who own more than 5% of a class must file a Schedule 13D or 13G.
16 securities where the latest filing since 12/18/2024 is a 13G, the newest filed 8/7/2026. View all